skip navigation links
National Cancer Institute
EVS Logo NCI Term Browser Enterprise Vocabulary Services
Terminologies Value Sets Mappings
Version: 17.12d (Release date: 2017-12-26)
SearchBox Top
SearchBox Bottom
Alogliptin (Code C76906)

Terms & Properties Synonym Details Relationships Mapping View All  
Terms & Properties

Preferred Name: Alogliptin

Definition: A selective, orally bioavailable, pyrimidinedione-based inhibitor of dipeptidyl peptidase 4 (DPP-4), with hypoglycemic activity. In addition to its effect on glucose levels, alogliptin may inhibit inflammatory responses by preventing the toll-like receptor 4 (TLR-4)-mediated formation of proinflammatory cytokines.

Label: Alogliptin

NCI Thesaurus Code: C76906 (Search for linked caDSR metadata)  (search value sets)

NCI Metathesaurus Link: C1958126  (see NCI Metathesaurus info)

Synonyms & Abbreviations: (see Synonym Details)
Benzonitrile, 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl]methyl]-

External Source Codes: 
CAS Registry Number 850649-61-5 (see NLM ChemIDplus info)
UMLS CUI C1958126

Other Properties:
     Name Value (qualifiers indented underneath)
Chemical_Formula C18H21N5O2
code C76906
Contributing_Source FDA
Legacy_Concept_Name Alogliptin
Semantic_Type Pharmacologic Substance

Additional Concept Data: 
Defined Fully by Roles: No  


Mainbox Bottom